Inflammatory ganglionopathies may benefit from treatments if administered timely.
Knowing the temporal profile of sensory neuron loss is a prerequisite.
Sensory action potentials (SNAPs) are surrogate markers of sensory neuron degeneration.
The therapeutic window to stabilize the patients is 8 months after onset.
The therapeutic window to improve the patient is 2 months after onset.